| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.06 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.06 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |